Mirum and Incyte gain approval of zilurgisertib for rare bone disorder
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
SpaceX sends investment trust Schiehallion rocketing
The net asset value of Schiehallion jumped 29% in the six months to July, driven by the stock market debuts of SpaceX and Italian tech group Bending Spoons.
[Weekly funding roundup Sept 19-25] VC inflow gets the debt boost
Venture capital funding into Indian startups surged this week, driven primarily by a handful of large deals.
Move Over, Tesla: This $140 Billion Company Looks Like a Superior Robotaxi Investment
Tesla faces stiff competition in the autonomous-vehicle rideshare market.
Kraken’s parent Payward is betting billions on becoming financial infrastructure, not just a crypto exchange
Kraken parent Payward is unifying trading, payments, asset management and institutional services on common rails, co-CEO Arjun Sethi said.
Warren Buffett's Top Advice for Investors Bracing for a Market Crash
It's always better to be overprepared than underprepared.
China-based Brics bank set for lead role in hunger alliance this year, Brazil says
The Brics-founded New Development Bank could help launch a fund by the end of the year to guarantee cheap loans for poor families in Africa and Latin America, Brazil’s social development minister…